Science
Mechanism of Action
Upon skin penetration, it is enzymatically converted into active kojic acid, which inhibits tyrosinase activity to reduce melanin synthesis. This mechanism, combined with its antioxidant properties, helps fade dark spots and brighten the complexion.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 A 0.1% nanoemulsion formulation demonstrated significant antioxidant and depigmenting efficacy, comparable to 1 mM ascorbic acid, without cytotoxicity up to 1%.
- 02 In situ studies on human melanocytes confirmed its pro-drug action, showing significant tyrosinase inhibition and reducing melanin in melanoma cells by 75%.
- 03 In vivo application on UVB-induced hyperpigmented guinea pig skin demonstrated clear depigmenting effects.
Transparency
Dusting Analysis
No specific data is available regarding the dusting potential of this ingredient.
The Formula
Formulation
Stability
Significantly more stable than kojic acid, resisting oxidation and discoloration. It should be stored in a cool, dark, and dry place, showing stability in nanoemulsion systems for up to 12 months.
Conflicts
- strong oxidizing agents
Safety
Safety Profile
Commonly used in commercial products at concentrations between 1% and 3%. Studies showed no cytotoxicity up to 1%, and it is considered gentler than pure kojic acid.
Your Skin
Skin Compatibility
Our Assessment
Verdict
This pro-drug offers effective, stable skin brightening and antioxidant benefits with improved tolerability compared to traditional kojic acid, making it a valuable ingredient for hyperpigmentation concerns.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources